Correlation Between Microsoft and Tscan Therapeutics

Can any of the company-specific risk be diversified away by investing in both Microsoft and Tscan Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Microsoft and Tscan Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Microsoft and Tscan Therapeutics, you can compare the effects of market volatilities on Microsoft and Tscan Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Microsoft with a short position of Tscan Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Microsoft and Tscan Therapeutics.

Diversification Opportunities for Microsoft and Tscan Therapeutics

0.82

Correlation Coefficient

Microsoft  Tscan Therapeutics

Very poor diversification

The 3 months correlation between Microsoft and Tscan is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding Microsoft and Tscan Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tscan Therapeutics and Microsoft is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Microsoft are associated (or correlated) with Tscan Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tscan Therapeutics has no effect on the direction of Microsoft i.e., Microsoft and Tscan Therapeutics go up and down completely randomly.

Pair Corralation between Microsoft and Tscan Therapeutics

Given the investment horizon of 90 days Microsoft is expected to generate 0.37 times more return on investment than Tscan Therapeutics. However, Microsoft is 2.73 times less risky than Tscan Therapeutics. It trades about -0.11 of its potential returns per unit of risk. Tscan Therapeutics is currently generating about -0.28 per unit of risk. If you would invest  42,398  in Microsoft on December 29, 2024 and sell it today you would lose (4,518) from holding Microsoft or give up 10.66% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Microsoft  vs.  Tscan Therapeutics

Microsoft

Risk-Adjusted Performance

Very Weak

Over the last 90 days Microsoft has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's technical and fundamental indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Tscan Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Tscan Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Microsoft and Tscan Therapeutics

The main advantage of trading using opposite Microsoft and Tscan Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Microsoft position performs unexpectedly, Tscan Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tscan Therapeutics will offset losses from the drop in Tscan Therapeutics' long position.

The idea behind Microsoft and Tscan Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.